Get to know us. Our independent credit research, global market insights, covenant analysis and news help the world’s financial decision makers manage risk better.
Bausch Health: Initial Impressions on the Strategic Alternatives Update
Anthony P. Canale, J.D.. - Global Head of Research, Covenant Review
EXECUTIVE SUMMARY
On February 6, Bausch Health Companies, Inc. (the “Company” or “BHC”) issued a press release updating the market on strategic alternatives (the “Strategic Update”). In this Strategic Update, the Company disclosed that the sale process it had engaged in regarding a potential sale of Bausch + Lomb Corporation (“B+L”) did not lead to an offer that reflected B+L’s long–term value, and the BHC and B+L boards determined not to move forward with a sale at this time. The Company also disclosed that it will continue its efforts to work on various liability management alternatives, including raising new debt financing.
In this report, we provide our initial impressions on the Strategic Update and how the provisions of the various Bausch Health bonds could be implicated.
Would you like access to the full report?
Receive a complimentary copy of Bausch Health: Initial Impressions on the Strategic Alternatives Update
Award-Winning, Completely Unbiased Research
On the investment grade and high yield securities of issuers around the globe.
Select an article to download a free piece of research.
Our Products
CreditSights combines credit market research, covenant analysis and leveraged finance news into one site to help you Know More. Risk Better.
Covenant Review
The Undisputed Authority on Bond & Loan Covenants.
Bixby
Market-moving news and premier financial data on the private broadly syndicated loan market.
Risk Products
Monitor, manage and mitigate risk effectively within your portfolio with our range of risk solution tools.
Private Credit
Our solution offers clients a detailed understanding of loan terms, risks, and financial nuances.